Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study-Reference-Cited by-同舟云学术

Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study

Published:2018-09-07 Issue:2 Volume:38 Page:457-463
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Fasano Serena,Margiotta Domenico Paolo Emanuele,Pierro Luciana,Navarini Luca,Riccardi Antonella,Afeltra Antonella,Valentini Gabriele

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/article/10.1007/s10067-018-4286-9/fulltext.html

Reference28 articles.

1. Bartels CM, Buhr KA, Goldberg JW, Bell CL, Visekruna M, Nekkanti S, Greenlee RT (2014) Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol 41(4):680–687

2. McMahon M, Hahn BH, Skaggs BJ (2011) Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention. Expert Rev Clin Immunol 7(2):227–241

3. Zeller CB, Appenzeller S (2008) Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev 4(2):116–122

4. Magder LS, Petri M (2012) Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol 176(8):708–719

5. Iudici M, Fasano S, Gabriele Falcone L, Pantano I, La Montagna G, Migliaresi S et al (2016) Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study. Rheumatology (Oxford) 55(9):1623–1630

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimalarial medications;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Lupus and the cardiovascular system;Dubois' Lupus Erythematosus and Related Syndromes;2025

3. Analisis Perbedaan Struktur Organisasi antara Perusahaan CV dan PT dalam Konteks Pengelolaan Sumber Daya Manusia;Indonesian Journal of Law and Justice;2024-05-27

4. The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus;Best Practice & Research Clinical Rheumatology;2023-12

5. Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up;Seminars in Arthritis and Rheumatism;2023-08